Aker BioMarine Valuation Multiples

Aker BioMarine is valued at $1.1B as of October 2026, a 5.6x revenue multiple. In the last 12 months, Aker BioMarine revenue was $233M and Aker BioMarine EBITDA was $48M.

Aker BioMarine Overview

About Aker BioMarine

Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Ingredients, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.


Founded

2006

HQ

Norway

Employees

255

Financials (LTM)

Revenue: $233M
EBITDA: $48M

EV

$1.3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Aker BioMarine Financials

Aker BioMarine reported last 12-month revenue of $233M and EBITDA of $48M.

In the same LTM period, Aker BioMarine generated $114M in gross profit, $48M in EBITDA, and $7M in net income.

Revenue (LTM)


Aker BioMarine P&L

In the most recent fiscal year, Aker BioMarine reported revenue of $218M and EBITDA of $32M.

Aker BioMarine is unprofitable as of last fiscal year, with gross margin of 45%, EBITDA margin of 15%, and net margin of (10%).

See analyst estimates for Aker BioMarine
LTMLast FY202320242025202620272028
Revenue$233M$218M$196M$199M$218M
Gross Profit$114M$98M$72M$78M$99M
Gross Margin49%45%37%39%45%
EBITDA$48M$32M$7M$35M$42M
EBITDA Margin20%15%4%17%19%
EBIT Margin10%6%(5%)(3%)8%
Net Profit$7M($23M)($9M)$183M($3M)
Net Margin3%(10%)(5%)92%(1%)
Net Debt-$164M---

Financial data powered by Morningstar, Inc.

Aker BioMarine Stock Performance

Aker BioMarine has current market cap of $1.1B, and enterprise value of $1.3B.

Market Cap Evolution


Aker BioMarine's stock price is $12.68.

Aker BioMarine share price increased by 5.7% in the last 30 days, and by 48.5% in the last year.

Aker BioMarine has an EPS (earnings per share) of $-0.26.

See more trading valuation data for Aker BioMarine
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.3B$1.1B0.0%5.7%9.3%48.5%$-0.26

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Aker BioMarine Valuation Multiples

Aker BioMarine trades at 5.6x EV/Revenue multiple, and 27.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Aker BioMarine

EV / Revenue (LTM)


Aker BioMarine Financial Valuation Multiples

As of October 29, 2026, Aker BioMarine has market cap of $1.1B and EV of $1.3B.

Aker BioMarine has a P/E ratio of 154.5x.

LTMLast FY202320242025202620272028
EV/Revenue5.6x6.0x6.6x6.5x6.0x
EV/EBITDA27.4x41.0x188.8x37.7x30.7x
EV/EBIT53.5x101.0x(125.3x)(245.8x)78.0x
EV/Gross Profit11.4x13.3x18.0x16.6x13.2x
P/E154.5x(48.8x)(123.5x)6.1xn/m
EV/FCF(205.7x)n/mn/m(120.6x)(205.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Aker BioMarine Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Aker BioMarine Margins & Growth Rates

Aker BioMarine grew revenue by 8% and EBITDA by 53% in the last fiscal year.

In the most recent fiscal year, Aker BioMarine reported gross margin of 45%, EBITDA margin of 15%, and net margin of (10%).

See estimated margins and future growth rates for Aker BioMarine

Aker BioMarine Margins

Last FY202420252026202720282029
Gross Margin45%39%45%46%
EBITDA Margin15%17%19%21%
EBIT Margin6%(3%)8%11%
Net Margin(10%)92%(1%)4%
FCF Margin(2%)(5%)(3%)0%

Aker BioMarine Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth8%1%10%9%
Gross Profit Growth13%8%26%11%
EBITDA Growth53%401%23%15%
EBIT Growth101%(49%)(415%)55%
Net Profit Growth(141%)(2129%)(101%)(443%)
FCF Growth(121%)500%(41%)(116%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Aker BioMarine Operational KPIs

Aker BioMarine's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.3M for the same period.

Aker BioMarine's Rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Aker BioMarine's Rule of X is 42% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Aker BioMarine
LTMLast FY202320242025202620272028
Rule of 4028%29%---
Bessemer Rule of X40%42%---
Revenue per Employee-$0.9M---
Opex per Employee-$0.3M---
S&M Expenses to Revenue-16%17%16%16%
G&A Expenses to Revenue-15%16%18%15%
R&D Expenses to Revenue-0%1%1%0%
Opex to Revenue-39%42%42%39%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Aker BioMarine Competitors

Aker BioMarine competitors include Mezzan Holding, Dongwon Industries, Princes Group, SOLIBRA Cote d'Ivoire, BellRing Brands, Italmobiliare, Seneca Foods, EID Parry India, AIR Global and Godrej Agrovet.

Most Aker BioMarine public comparables operate across Food & Beverages.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Mezzan Holding$961M$113M1.5x1.4x12.6x9.0x
Dongwon Industries$7.2B$646M0.4x0.4x4.4x4.5x
Princes Group$2.5B$198M0.3x0.3x4.0x3.6x
SOLIBRA Cote d'Ivoire------
BellRing Brands$2.3B$376M0.9x0.9x5.8x7.5x
Italmobiliare$865M$193M2.0x1.9x9.0x10.3x
Seneca Foods$1.7B$211M0.7x0.7x5.7x6.3x
EID Parry India$2.9B$320M0.8x0.6x7.4x6.5x

This data is available for Pro users. Sign up to see all Aker BioMarine competitors and their valuation data.

Start Free Trial

Acquisitions by Aker BioMarine

Aker BioMarine has acquired 1 company to date.

Last acquisition by Aker BioMarine was on August 8th 2017. Aker BioMarine acquired Neptune (Krill Oil inventory and IP) for $35M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Aker BioMarine

Neptune (Krill Oil inventory and IP)
Description
Neptune is a marine ingredient supplier that holds intellectual property and inventory for krill oil under the NKO brand, sourced from Antarctic waters. It provides phospholipid-rich krill oil, marine lipids, and specialty seed oils to supplement manufacturers in North America and Europe. The Quebec-based company maintains a global supply network for omega-3 concentrates and astaxanthin extracts used in nutritional supplements.
HQ CountryCanada
HQ City
Laval
Deal Date8 Aug 2017
Valuation$35M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Aker BioMarine acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Aker BioMarine

When was Aker BioMarine founded?Aker BioMarine was founded in 2006.
Where is Aker BioMarine headquartered?Aker BioMarine is headquartered in Norway.
How many employees does Aker BioMarine have?As of today, Aker BioMarine has over 255 employees.
Is Aker BioMarine publicly listed?Yes, Aker BioMarine is a public company listed on Oslo Børs.
What is the stock symbol of Aker BioMarine?Aker BioMarine trades under AKBM ticker.
When did Aker BioMarine go public?Aker BioMarine went public in 2020.
Who are competitors of Aker BioMarine?Aker BioMarine main competitors include Mezzan Holding, Dongwon Industries, Princes Group, SOLIBRA Cote d'Ivoire, BellRing Brands, Italmobiliare, Seneca Foods, EID Parry India, AIR Global, Godrej Agrovet.
What is the current market cap of Aker BioMarine?Aker BioMarine's current market cap is $1.1B.
What is the current revenue of Aker BioMarine?Aker BioMarine's last 12 months revenue is $233M.
What is the current revenue growth of Aker BioMarine?Aker BioMarine revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Aker BioMarine?Current revenue multiple of Aker BioMarine is 5.6x.
What is the current EBITDA of Aker BioMarine?Aker BioMarine's last 12 months EBITDA is $48M.
What is Aker BioMarine's EBITDA margin?Aker BioMarine's last 12 months EBITDA margin is 20%.
What is the current EV/EBITDA multiple of Aker BioMarine?Current EBITDA multiple of Aker BioMarine is 27.4x.
What is the current FCF of Aker BioMarine?Aker BioMarine's last 12 months FCF is ($6M).
What is Aker BioMarine's FCF margin?Aker BioMarine's last 12 months FCF margin is (3%).
What is the current EV/FCF multiple of Aker BioMarine?Current FCF multiple of Aker BioMarine is (205.7x).
How many companies Aker BioMarine has acquired to date?As of October 2026, Aker BioMarine has acquired 1 company.
What was the largest acquisition by Aker BioMarine?$35M acquisition of Neptune (Krill Oil inventory and IP) on 8th August 2017 was the largest M&A Aker BioMarine has done to date.
What companies Aker BioMarine acquired?Aker BioMarine acquired Neptune (Krill Oil inventory and IP).
In how many companies Aker BioMarine has invested to date?Aker BioMarine hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Aker BioMarine

Lists including Aker BioMarine

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial